Prescient is an evidence-based decision-support partner to the pharmaceutical and biotech industries whose mission is to optimally shape new product, brand and mature product planning strategies.

Our diverse yet integrated skillsets and methodologies ensure our clients’ key decisions are objectively assessed from both a clinical and commercial perspective, resulting in differentiated products and offerings.


Shaping Decisions Driving Value

Our People

Prescient’s team consists of highly experienced executives who share our core values of thinking collaboratively, creatively and constructively. We effectively integrate different skills and perspectives into a single client-engagement team.

Our Approach

The format and scope of our engagements are customized to meet our clients’ needs and our ‘best-in-front’ team philosophy ensures access to the necessary levels of expertise and thinking.

Our Clients

We engage directly with a number of functions supporting new product, brand and mature product planning activities; to view a full list of these, please click the
link below.

Latest News

Califf, FDA top officials call for sweeping review of agency opioids policies

Use of and barriers to access to opioid analgesics worldwide

Bristol-Myers Squibb and Pfizer sign collaboration with Portola Pharmaceuticals

New drug target for Rett syndrome

Bristol-Myers Squibb Foundation awards eight grants totaling nearly $11.5M to make lung and skin can …

Abbott to Acquire Alere, becoming leader in point of care testing

Cholesterol levels improve with weight loss and healthy fat-rich diet

FDA approves first drug to show survival benefit in liposarcoma

New drug could be safer, non-addictive alternative to morphine

Merck announces new biopharma heads for North America and China

Ancient medicinal clay shows promise against today's worst bacterial infections

European Commission confirms CMDh recommendation: Benefit/risk profiles of ambroxol and bromhexine p …

New mechanism of antitumor action identified

The effects of the Trans-Pacific Partnership on pharmaceutical innovation

Human medicines: highlights of 2015

UPDATED: A patient in Akashi's suspended Duchenne MD trial dies

Celltrion's take on J&J's Remicade is 'highly similar' to the original, FDA …

Shire's self-described blockbuster eye drug lines up for FDA do-over

OncoGenex slashes 27% of its payroll as its pipeline promise fades

Marc Tessier-Lavigne named Stanford's next president

Hit with a storm of protest, LifeSci Advisors apologizes for its J.P. Morgan party

French investigators to Biotrial: You should have stopped fatal study earlier

U.K. public life science investment hits £1.3B; Mission bags £60M; Pierre Fabre starts VC fund

Thomson Reuters spotlights the R&D trends behind 2016's top blockbusters

Osiris CEO steps down for 'personal reasons'

FDA Breakthrough status for Immunomedics breast cancer candidate

Government body says UK Cancer Drugs Fund not effectively managed

Statins could potentially treat dry AMD: study

Johnson & Johnson to co-develop stem cell-based treatments for diabetes with ViaCyte

Takeda buys rights to Mersana’s XMT-1522 outside USA and Canada

FDA top officials call for sweeping review of agency opioids policies

Sanofi appoints Muzammil Mansuri as executive vice president, strategy & business development

Dutch EUC Presidency priorities in the field of pharmaceuticals

Over 1 in 4 new drugs approved by FDA in 2015 are personalized medicines

BIO Releases first-ever industry Principles on Value of Biopharmaceuticals

MHRA adds Bristol-Myers Squibb‘s cancer drug to early access scheme

FDA approves new indication for Merck’s Emend

Seattle Genetics gets $20 million milestone from Takeda

Tollys SAS gets rights to Riboxx Pharma’s Apoxxim

Takeda to spin out consumer health business

Medical News Today: Eradicating mitochondria from cells may reverse aging

Medical News Today: Can herpes contribute to cognitive decline?

Medical News Today: Mosquitos and Zika: the insect behind the outbreak

Medical News Today: Mysterious allergy to vibrations: gene provides clue

Medical News Today: 'Stop using BMI as measure of health,' say researchers

Medical News Today: Lifespan in mice increased by clearing out senescent cells

Medical News Today: Rest after concussion to avoid 'sustained brain damage'

Medical News Today: Americans 'at 10 times greater risk of gun death'

Medical News Today: Flu Symptoms (Influenza Symptoms): Signs, Duration, Complications

Medical News Today: Saliva may provide early test for Parkinson's disease

Medical News Today: Obesity associated with ADHD in females

Medical News Today: Schizophrenia breakthrough: scientists shed light on biological cause

Medical News Today: Meditation shown to reduce pain during breast cancer biopsy

Medical News Today: 'No evidence that CT scans, X-rays cause cancer'

Medical News Today: Model shows cancer's birth and spread from single cell

J&J, ViaCyte step up search for diabetes cure

Report slams Cancer Drugs Fund management

Statins show promise in treating sight-loss condition AMD

Bed blocking costs the NHS £900 million a year

UK lung cancer patients get early access to BMS' Opdivo

New US nod for Merck's nausea and vomiting drug

SBRI hands six UK firms £4.4m in latest competition

MRC moves to fast-track Zika virus research

FDA advisors back expanding Takeda, Lundbeck's Brintellix

2016 profit warning from AstraZeneca

More News